Health news
Big pharma urges Commission to slow down new critical medicines rules
With the date of publication for a Critical Medicines Act fast approaching, the EU’s pharma industry is urging the Commission to slow down rather than keeping to a promise made by Health Commissioner Oliver Várhelyi to launch the proposal within the first 100 days of his mandate.
ADVERTISEMENT
Business
European Commission fines MS drug maker Teva over improper patent use
The European Commission says it has fined the Israeli generic drug maker, Teva, more than €460m for improperly seeking to protect the patent for its multiple sclerosis drug and for disparaging a rival company's development of a competing medicine.
Healthcare
Surging drug costs straining national budgets, health insurers warn
Rising pharmaceutical prices, particularly for novel therapies and cancer treatments, are driving increased health spending across Europe, placing significant strain on national budgets, according to a new study published this week.
